Results 181 to 190 of about 29,549 (204)

Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach. [PDF]

NPJ Precis Oncol
Amidi E, Ramzanpour M, Chen M, Boucher T, Varma M, Samec T, Lamon B, Stransky N, Miglarese MR, Oberley M, Spetzler D, Sledge GW.   +11 more
europepmc   +1 more source

Peer Methods for the Solution of Large-Scale Differential Matrix Equations

Benner, P., Lang, N.
core  

The Association Between Thromboembolic Events and ALK, ROS1, RET Rearrangements or EGFR Mutations in Patients With Advanced Lung Adenocarcinoma: A Retrospective Cohort Study. [PDF]

Thorac Cancer
Qian X, Fu M, Zheng J, Chen J, Cai C, Zhou J, Zhou J.   +6 more
europepmc   +1 more source

Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant Mutations. [PDF]

Mol Cancer Ther
Tangpeerachaikul A, Mente S, Magrino J, Gu F, Horan JC, Pelish HE.   +5 more
europepmc   +1 more source

Molecular Characteristics and Treatment Implications of TP53 Gain-of-Function Mutations in Non-Small Cell Lung Cancer. [PDF]

Cancer Med
Zhao Z, Lu R, Zhang F, Chen H, Ou Q, Zhao X, Hong X, Bao H, Lu D, Min J.   +9 more
europepmc   +1 more source

Combination of chemotherapy and immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1 mutations: a retrospective observational study. [PDF]

BMC Cancer
Shin JE, Park S, Jung HA, Sun JM, Lee SH, Ahn JS, Ahn MJ.   +6 more
europepmc   +1 more source

The Landscape of Bispecific Antibodies in Solid Tumor Oncology: Trends, Challenges, and Opportunities. [PDF]

Cancer Med
ElBeblawy R, Jani C, Pérez-Granado J, Gramling M, Desai A.   +4 more
europepmc   +1 more source

<i>ROS1</i> fusion-positive non-small cell lung cancer-repotrectinib as a new treatment option. [PDF]

Transl Cancer Res
Rothschild SI, Mauti LA.
europepmc   +1 more source

Remarkable response to crizotinib in a patient with advanced lung adenocarcinoma harboring the MPRIP-ROS1 fusion gene: A case report. [PDF]

Respir Med Case Rep
Kishikawa Y, Otsubo K, Shibahara D, Shiraishi Y, Yoneshima Y, Iwama E, Okamoto I.   +6 more
europepmc   +1 more source

Liquid Biopsy in Lung Cancer: Tracking Resistance to Targeted Therapies. [PDF]

Cancers (Basel)
Urtecho SB, Jimenez Munarriz B, Rabey MR, Leighl NB.   +3 more
europepmc   +1 more source